Aspira Pathlab & Diagnostics Share Price

BSE
ASPIRA •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Aspira Pathlab & Diagnostics Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
New 52W High in past week
110.2
TTM PE Ratio
Negative PE TTM
-251.6
Price to Book Ratio
Above industry Median
6.7
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is negative
-3.2

Aspira Pathlab & Diagnostics Ltd shareholding Pattern

Promoter
18.6%
Public
81.5%
Promoter
18.7%
Public
81.3%
Promoter
18.7%
Public
81.3%
Promoter
18.9%
Public
81.1%
Promoter
18.9%
Public
81.1%
Promoter
19.4%
Public
80.6%

Aspira Pathlab & Diagnostics Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
15
Bearish Moving Averages
1
5Day EMA
65.40
10Day EMA
63.00
12Day EMA
62.00
20Day EMA
58.70
26Day EMA
56.50
50Day EMA
50.30
100Day EMA
43.60
200Day EMA
39.10
5Day SMA
66.40
10Day SMA
62.80
20Day SMA
57.60
30Day SMA
53.90
50Day SMA
48.00
100Day SMA
39.70
150Day SMA
36.60
200Day SMA
35.80
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
3549 Rs
3549 Rs
Week Rs
5341 Rs
5341 Rs
Month Rs
4859 Rs
4859 Rs
Resistance & Support
65.87
Pivot
Resistance
First Resistance
67.43
Second Resistance
70.57
Third Resistance
72.13
Support
First Support
62.73
Second support
61.17
Third Support
58.03
Relative Strength Index
67.76
Money Flow Index
67.82
MACD
5.53
MACD Signal
4.92
Average True Range
3.59
Average Directional Index
35.65
Rate of Change (21)
31.92
Rate of Change (125)
107.69

Aspira Pathlab & Diagnostics Ltd Company background

Founded in: 1973
Managing director: Pankaj Jashwant Shah
Aspira Pathlab Diagnostics Limited (ASDL) was incorporated in July, 1973. ASDL is a leading pathology specialist, with PanIndia presence. It offer pathology and diagnostic services to individual patients, hospitals, other healthcare providers, and businesses. The Company, with a wider presence in Maharashtra India, enjoys a loyal customer base, that reflects on its strength as a brand, providing superior diagnostic testing and services.Presently, Company is engaged into the business of running, owning, managing and administering Diagnostics Centers. Its principal activities consist of pathology investigation services, radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai.During the year, the Company commenced its business activities of diagnostic center pathology from November 2016 onwards by acquiring running business activities of Ankur Pathology Laboratory. Aspira is focused on establishing itself as a strong regional player before scaling up its operations. Although, it follow an asset light model, other costs are significantly high. Most of these cost is front ended and the payback period is high. It is therefore working on building the right systems and optimize the cost. It is adopting new technologies that improve customer experience. Some of these are use of Chatbot, improving website, implementing patient engagement platform, Customer Service, etc. Also concentrating more on HLM, trying to expand area by targeting newly setup hospitals and laboratory and trying to achieve more technology and advancement.
Read More

Aspira Pathlab & Diagnostics Ltd FAQs

You can easily buy Aspira Pathlab & Diagnostics Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -